Ian Gilham

Multiplicom NV develops, manufactures, and commercializes molecular diagnostics solutions. It specializes in pathology laboratories, next generation sequencing, multiplex amplification of specific targets for resequencing, genetics, assay kits, clinical laboratories, and personalized medicine. The company was founded by Chris De Jonghe in 2011 and is headquartered in Niel, Belgium.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Stowheath Ltd. is a British company that provides professional, scientific, and technical services. The private company is based in London, UK. The company was founded in 2011.

Concepta Diagnostics Ltd. engages in the development of products for the female health diagnostics sector. The company was founded by Steven Koon Ching Lee and Robert Andrew Porter on January 15, 2013 and is headquartered in Cardiff, the United Kingdom.

Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom.

Delta Diagnostics Ltd. develops and provides assays diagnostics solutions. It offers cystic fibrosis, rapid aneuploidy analysis, and genetic disease diagnosis. The company was founded in 1994 and is headquartered in Lancashire, the United Kingdom.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson.